Table 2.
Treatment effect h of NTX-BUP vs. Placebo within and between race/ethnicity status.
|
PHQ-9 |
TEA Total score |
MA Craving |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Racial and ethnic Subgroups | h(95% CI) | P-value‡ | P-value† | h(95% CI) | P-value‡ | P-value† | h(95% CI) | P-value‡ | P-value† |
| Non-Hispanic White | -0.8 (1.9, 0.4) | 0.77 | Ref | 3.1 (0.9, 5.3) | 0.01 | Ref | -9.3 (-14.7, −3.7) | <0.01 | Ref |
| Non-Hispanic Black | -0.7 (-3.8, 2.4) | 0.99 | 0.99 | 0.4 (-4.1, 4.9) | 0.99 | 0.84 | -13.5 (-26.5, −0.6) | 0.16 | 0.99 |
| Hispanic | -2.8 (-5.5, −0.1) | 0.18 | 0.56 | 7.8 (2.5, 13.1) | 0.01 | 0.32 | -7.7 (-17.9, 2.4) | 0.54 | 0.99 |
| Non-Hispanic Other | -2.9 (-5.8, 0.0) | 0.22 | 0.53 | 7.9 (2.8, 13.1) | 0.00 | 0.25 | -13.0 (-28.1, 2.1) | 0.36 | 0.99 |
Note: ‡P-values are for mean change from baseline in treatment effect h within racial and ethnic subgroups and were adjusted for 4 multiple comparisons using the Bonferroni correction; †P-values are for comparisons in treatment effect h between racial and ethnic subgroups and were adjusted for 3 multiple comparisons using the Bonferroni correction